Financial Gravity Asset Management, Inc. Bio Techne Corp Transaction History

Financial Gravity Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 28, 2020	SELL	$189.68 - $222.09 $1,896 - $2,220	-10 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$188.72 - $215.43 $49,067 - $56,011	-260 Reduced 96.3%	10 $2,000
Q1 2019 Apr 19, 2019	BUY	$136.09 - $200.44 $952 - $1,403	7 Added 2.66%	270 $54,000
Q3 2018 Oct 31, 2018	BUY	$147.44 - $204.11 $36,860 - $51,027	250 Added 1923.08%	263 $47,000
Q2 2018 Aug 14, 2018	SELL	$144.9 - $165.58 $30,863 - $35,268	-213 Reduced 94.25%	13 $2,000
Q1 2018 May 23, 2018	BUY	$131.46 - $151.04 $29,709 - $34,135	226 New	226 $33,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.